drugset / Trial / NCT02798159

Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction

NCT02798159

Phase 2/3 Completed 168 enrolled Vietstar Biomedical Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to identify the optimal dose(s) of TD0025 for treatment of erectile dysfunction (phase II) and to investigate if treatment of erectile dysfunction with the optimal dose of TD0025 taken as needed over one month is non-inferior than Sildenafil Citrate taken as needed over one month (phase III)

Timeline

Start
2016-05
Primary completion
2018-03-01
Completion
2018-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 50 mg Oral
Subject TD0025 Unknown Oral

Indications